Long-term pharmacokinetic and pharmacological evaluations of a novel indole-benzazepinone derivative on obese T2DM - Supplementary material

Table 1. Effects of the tested compounds on insulin in obese hyperglycemic DIO mouse model Fig. 1 Effects of the tested compounds on food consumption in obese hyperglycemic DIO mouse model induced by HFD Table 2. Effects of the continuous administration of the test compounds on the biochemical parameters of obese hyperglycemic DIO mouse model induced by HFD Table 3. Effects of the tested compounds on liver in obese hyperglycemic DIO mouse model induced by HFD Fig. 2 Effects of the tested compounds on liver organs coefficients in obese hyperglycemic DIO mouse model induced by HFD